“alzheimers” Archives

in
Entry Author Date Location
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists 05/01/19 San Diego
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding 04/30/19 Texas
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More 02/15/19 National
Hypergiant in Space, Celltex & Saudi, Siete Foods’ $90M, & More TX Tech 02/07/19 Texas
Dewpoint Debuts with $60M to Target Protein Droplets Linked to Disease 01/30/19 Boston
Eli Lilly Partners with AC Immune on Tau Blockers for Alzheimer’s 12/12/18 Indiana
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel 11/09/18 National
Rainwater Foundation Deploys Millions Toward Rare Brain Disease, PSP 11/07/18 Texas
Win $2 Million to Solve Alzheimer’s: New Prize Will Reward Fresh Ideas 11/05/18 Texas
Fresh Data Add More Confusion to Eisai-Biogen Alzheimer’s Drug 10/25/18 Boston
Still Seeking Pharma Partner, Phoenix Bio Adds $1M in Angel Funding 10/25/18 Texas
New Biotech Magnolia Neurosciences Gets $31M For Neuroprotective Drugs 08/13/18 New York
PureTech Health’s Karuna Snags $42M Series A for Schizophrenia Drug 08/02/18 Boston
10 Must-Read Stories From Xconomy (and Elsewhere) This Week 07/27/18 National
Care2Rock, Moneta, Yoshi, CipherLoc, Charles Schwab, & More TX Tech 05/14/18 Texas
Wave, Takeda Target RNA Technology at Neuro Diseases With $230M Pact 02/20/18 Boston
Xconomy Newcomer Award Winner Amy Schulman on Boston Biotech Life 11/06/17 Boston
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial 09/18/17 Boston
Alzeca Receives $11M for Early Alzheimer’s Detection Technology 08/17/17 Texas
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points 08/07/17 Texas
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
With Latest Deal, Biogen Bets $120M on Remedy Pharma Stroke Drug 05/15/17 Boston
Texas Roundup: Joshua Baer, UTD, Prytime, Next Coast, Spanning 05/01/17 Texas
Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment 04/20/17 Texas
After Medivation Sale, ex-CEO David Hung Lands Top Spot At Axovant 04/10/17 San Francisco
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
Page 1 of 7 next page »